In contrast, LBH has been shown to be downregulated in nasopharyngeal and lung cancer, and to exert tumor-suppressive, non-invasive effects, in part by inducing G1/S cell cycle arrest downstream of TGFß and attenuating NF-κB transcriptional activity [21–23]. This evidence concerns the gene LBH and lung cancer.